Compare IRTC & RUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRTC | RUN |
|---|---|---|
| Founded | 2006 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.1B |
| IPO Year | 2016 | 2015 |
| Metric | IRTC | RUN |
|---|---|---|
| Price | $121.66 | $12.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 20 |
| Target Price | ★ $197.92 | $18.80 |
| AVG Volume (30 Days) | 381.0K | ★ 7.6M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 61.71 | ★ 113.35 |
| EPS | N/A | ★ 1.71 |
| Revenue | $747,138,000.00 | ★ $858,578,000.00 |
| Revenue This Year | $19.60 | $2.81 |
| Revenue Next Year | $15.94 | $4.54 |
| P/E Ratio | ★ N/A | $6.87 |
| Revenue Growth | ★ 26.24 | 12.97 |
| 52 Week Low | $103.16 | $5.38 |
| 52 Week High | $210.01 | $22.44 |
| Indicator | IRTC | RUN |
|---|---|---|
| Relative Strength Index (RSI) | 48.55 | 47.16 |
| Support Level | $119.48 | $12.01 |
| Resistance Level | $124.40 | $13.57 |
| Average True Range (ATR) | 4.54 | 0.70 |
| MACD | 1.02 | 0.03 |
| Stochastic Oscillator | 55.42 | 34.43 |
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.